214 related articles for article (PubMed ID: 26731428)
1. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
2. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
Yu XZ; Guo ZY; Di Y; Yang F; Ouyang Q; Fu DL; Jin C
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):104-109. PubMed ID: 28119265
[TBL] [Abstract][Full Text] [Related]
3. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis.
Yang X; Xia Y; Wang S; Sun C
PLoS One; 2022; 17(8):e0273317. PubMed ID: 35981080
[TBL] [Abstract][Full Text] [Related]
6. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study.
Sinn M; Sinn BV; Striefler JK; Lindner JL; Stieler JM; Lohneis P; Bischoff S; Bläker H; Pelzer U; Bahra M; Dietel M; Dörken B; Oettle H; Riess H; Denkert C
Ann Oncol; 2014 May; 25(5):1025-32. PubMed ID: 24562449
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis.
Han W; Shi CT; Cao FY; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; He DW; Wang QH; Wang JF; Xu XX; Ding HZ
PLoS One; 2016; 11(8):e0160547. PubMed ID: 27518571
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of B7H1 and B7H4 expression in pancreatic cancer: A meta-analysis.
Qi ZJ; Yu D; Chen CH; Jiang H; Li R; Kang YM
Int J Biol Markers; 2019 Dec; 34(4):373-380. PubMed ID: 31608800
[TBL] [Abstract][Full Text] [Related]
12. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis.
Feng S; Mu H; Hou R; Liu Y; Zou J; Zhao Z; Zhu Y
Int J Clin Oncol; 2022 Jul; 27(7):1127-1138. PubMed ID: 35604501
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of human equilibrative nucleoside transporter1 in pancreatic cancer receiving gemcitabin-based chemotherapy: a meta-analysis.
Liu ZQ; Han YC; Zhang X; Chu L; Fang JM; Zhao HX; Chen YJ; Xu Q
PLoS One; 2014; 9(1):e87103. PubMed ID: 24475233
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
18. SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.
Hidalgo M; Plaza C; Musteanu M; Illei P; Brachmann CB; Heise C; Pierce D; Lopez-Casas PP; Menendez C; Tabernero J; Romano A; Wei X; Lopez-Rios F; Von Hoff DD
Clin Cancer Res; 2015 Nov; 21(21):4811-8. PubMed ID: 26169969
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
